ARHGAP39 is a prognostic biomarker involved in immune infiltration in breast cancer. Yao L, Li Y, Li S, Wang M, et al. BMC Cancer 2023;23:440.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yao L, Li Y, Li S, Wang M, et al. ARHGAP39 is a prognostic biomarker involved in immune infiltration in breast cancer. BMC Cancer 2023;23:440.
PMID: 37189064